HER2 Support Group Forums - View Single Post - Positive safety data from BioSante's ongoing LibiGel Phase III study for HSDD treatme

News · 02-13-2011, 09:20 PM

BioSante Pharmaceuticals, today announced positive safety data in its ongoing LibiGel Phase III clinical development program.

More...

02-13-2011, 09:20 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,987	Positive safety data from BioSante's ongoing LibiGel Phase III study for HSDD treatme BioSante Pharmaceuticals, today announced positive safety data in its ongoing LibiGel Phase III clinical development program. More...